Healthcare provider profile · identity verified

Joanna Setla, MD

Internal Medicine · EAU CLAIRE, WI · NPI 1982684163

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	697	179
Atorvastatin Calcium	Atorvastatin Calcium	640	185
Amlodipine Besylate	Amlodipine Besylate	622	181
Atenolol	Atenolol	404	114
Losartan Potassium	Losartan Potassium	392	108
Metoprolol Succinate	Metoprolol Succinate	392	103
Furosemide	Furosemide	352	103
Potassium Chloride	Potassium Chloride	337	87
Omeprazole	Omeprazole	330	111
Alprazolam	Alprazolam	268	57
Metoprolol Tartrate	Metoprolol Tartrate	262	81
Rosuvastatin Calcium	Rosuvastatin Calcium	254	83
Lisinopril	Lisinopril	251	84
Tramadol Hcl	Tramadol Hcl	249	63
Pantoprazole Sodium	Pantoprazole Sodium	241	64
Eliquis	Apixaban	240	54
Sertraline Hcl	Sertraline Hcl	226	65
Gabapentin	Gabapentin	224	66
Simvastatin	Simvastatin	198	64
Metformin Hcl	Metformin Hcl	186	55
Famotidine	Famotidine	162	55
Hydrochlorothiazide	Hydrochlorothiazide	157	50
Alendronate Sodium	Alendronate Sodium	155	48
Metformin Hcl Er	Metformin Hcl	131	33
Pravastatin Sodium	Pravastatin Sodium	129	35
Duloxetine Hcl	Duloxetine Hcl	118	35
Trazodone Hcl	Trazodone Hcl	115	45
Albuterol Sulfate Hfa	Albuterol Sulfate	107	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	34
Prednisone	Prednisone	102	55
Isosorbide Mononitrate Er	Isosorbide Mononitrate	101	21
Baclofen	Baclofen	99	37
Mirtazapine	Mirtazapine	99	26
Warfarin Sodium	Warfarin Sodium	93	27
Ozempic	Semaglutide	89	17
Tamsulosin Hcl	Tamsulosin Hcl	88	20
Clopidogrel	Clopidogrel Bisulfate	86	22
Lovastatin	Lovastatin	82	21
Paroxetine Hcl	Paroxetine Hcl	80	24
Fluoxetine Hcl	Fluoxetine Hcl	79	28
Quetiapine Fumarate	Quetiapine Fumarate	76	suppressed
Ezetimibe	Ezetimibe	71	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	31
Carvedilol	Carvedilol	67	17
Lorazepam	Lorazepam	67	22
Glimepiride	Glimepiride	66	19
Citalopram Hbr	Citalopram Hydrobromide	64	22
Fluticasone Propionate	Fluticasone Propionate	63	26
Synthroid	Levothyroxine Sodium	63	20
Escitalopram Oxalate	Escitalopram Oxalate	61	20
Januvia	Sitagliptin Phosphate	59	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	16
Hydralazine Hcl	Hydralazine Hcl	56	23
Montelukast Sodium	Montelukast Sodium	56	15
Pregabalin	Pregabalin	53	11
Spironolactone	Spironolactone	53	17
Glipizide	Glipizide	52	15
Nifedipine Er	Nifedipine	51	12
Oxybutynin Chloride Er	Oxybutynin Chloride	51	17
Allopurinol	Allopurinol	50	18
Doxazosin Mesylate	Doxazosin Mesylate	50	14
Lamotrigine	Lamotrigine	50	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	16
Meloxicam	Meloxicam	49	20
Venlafaxine Hcl Er	Venlafaxine Hcl	49	13
Bupropion Hcl Sr	Bupropion Hcl	47	14
Trulicity	Dulaglutide	46	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	12
Zolpidem Tartrate	Zolpidem Tartrate	45	18
Estradiol	Estradiol	44	24
Torsemide	Torsemide	42	14
Oxycodone Hcl	Oxycodone Hcl	41	15
Triamcinolone Acetonide	Triamcinolone Acetonide	41	30
Bupropion Xl	Bupropion Hcl	40	12
Acetaminophen-Codeine	Acetaminophen With Codeine	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	13
Nitroglycerin	Nitroglycerin	38	12
Propranolol Hcl	Propranolol Hcl	38	suppressed
Solifenacin Succinate	Solifenacin Succinate	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	12
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Cephalexin	Cephalexin	30	24
Clonazepam	Clonazepam	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	11
Levetiracetam	Levetiracetam	30	suppressed
Acyclovir	Acyclovir	28	13
Enalapril Maleate	Enalapril Maleate	28	suppressed
Verapamil Er	Verapamil Hcl	28	suppressed
Amoxicillin	Amoxicillin	27	16
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Topiramate	Topiramate	24	suppressed
Ventolin Hfa	Albuterol Sulfate	23	13
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Hydrocortisone	Hydrocortisone	22	13
Benazepril Hcl	Benazepril Hcl	21	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Cefuroxime	Cefuroxime Axetil	21	17
Diazepam	Diazepam	20	suppressed
Metronidazole	Metronidazole	20	13
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Estradiol (Once Weekly)	Estradiol	17	suppressed
Methylprednisolone	Methylprednisolone	17	16
Nabumetone	Nabumetone	17	suppressed
Trimethoprim	Trimethoprim	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Felodipine Er	Felodipine	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Nyamyc	Nystatin	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	12
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Ramipril	Ramipril	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ramelteon	Ramelteon	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Nystatin	Nystatin	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error